Skip to content
PubMed This is a summary of 64 peer-reviewed journal articles Updated
Pediatric Endocrinology · Congenital Lipoid Adrenal Hyperplasia

Congenital Lipoid Adrenal Hyperplasia (STAR Deficiency): A Patient Guide

At a Glance

Congenital lipoid adrenal hyperplasia (STAR deficiency) is a lifelong genetic condition that limits cortisol, aldosterone, and sex hormone production. Children need consistent hormone replacement, illness-related stress dosing, and an emergency hydrocortisone plan.

Congenital Lipoid Adrenal Hyperplasia (LCAH), also known as STAR deficiency, is an exceptionally rare genetic condition that fundamentally changes how the body produces essential steroid hormones. In a healthy body, cholesterol serves as the “building block” for hormones that regulate everything from salt balance and blood sugar to physical development. In children with STAR deficiency, a specific protein—the StAR protein—is unable to transport this cholesterol into the part of the cell where it can be transformed into these steroids [1][2]. As a result, the body faces a shortage of cortisol, aldosterone, and sex hormones, while unused cholesterol builds up as tiny fat droplets (lipids) within the adrenal glands and gonads [3].

This condition typically follows one of two paths based on the severity of the genetic change. The classic form is the most severe and usually appears within the first few weeks or months of life, often through symptoms like persistent vomiting, poor weight gain, or a “salt-wasting” crisis where the body cannot maintain its sodium levels [4]. The non-classic form is more subtle, often appearing later in childhood with milder symptoms; these individuals may retain meaningful steroid production, though it still requires lifelong vigilance [3][5]. Because the StAR protein is also essential for making sex hormones, the condition can also influence how a child’s body develops physically before birth and during puberty, leading to unique developmental journeys that vary depending on each child’s specific genetic blueprint and variable ovarian or testicular function [2][6].

What To Do Today Checklist

  • Emergency Kit: Ensure your emergency injectable hydrocortisone kit is unexpired and easily accessible.
  • Action Plan: Ask your clinician to provide a signed, individualized written emergency action plan that fills in the exact oral and injectable doses for your child.
  • Medical Alert: Ensure the child is wearing a medical alert bracelet.

Living with STAR deficiency is a lifelong commitment to balance, but it is a journey that many families navigate successfully. The core of daily management is replacing the hormones the body cannot make on its own through consistent, timed medications [7]. Beyond daily pills, the most critical skill for any caregiver is “stress dosing”—learning how to increase medication during times of fever or illness to prevent a medical emergency known as an adrenal crisis [6][8]. While the technical details of labs and dosing can feel overwhelming at first, the primary goal of your medical team is to ensure your child remains energetic, grows at a healthy rate, and can participate in all the typical activities of childhood [9].

Though the diagnosis is permanent, it does not define your child’s potential. With a dedicated care team—usually led by a pediatric endocrinologist—and a solid emergency plan in place, children with STAR deficiency grow, learn, and thrive [9]. As they transition through puberty and into adulthood, they will continue to work with specialists to monitor their health and explore future options for fertility and family planning [10][11]. You are not alone in this process; while the condition is rare, the medical community’s understanding of how to support these children continues to advance, focusing on a future that is bright, active, and full of possibility [12][13].

Common questions in this guide

What is congenital lipoid adrenal hyperplasia caused by STAR deficiency?
It is a rare genetic condition in which the StAR protein cannot move cholesterol into the part of the cell needed to make steroid hormones. This can lead to low cortisol, aldosterone, and sex hormones, while cholesterol accumulates in the adrenal glands and gonads.
How are classic and non-classic STAR deficiency different?
The classic form is more severe and often appears in the first weeks or months of life with vomiting, poor weight gain, or a salt-wasting crisis. The non-classic form usually appears later and may leave some steroid production. Your child’s medical team can explain which form is present and how it affects monitoring and daily medication.
What is stress dosing for a child with STAR deficiency?
Stress dosing means temporarily increasing hormone-replacement medicine during fever or illness, according to the child’s individualized plan. It helps prevent an adrenal crisis, so caregivers should know when to give oral medicine, when injectable hydrocortisone is needed, and when to seek urgent help.
What should be in a STAR deficiency emergency plan?
Keep an unexpired injectable hydrocortisone kit where caregivers can quickly find it, and ask the clinician for a signed written plan with the child’s exact oral and injectable doses. The child should also wear medical alert identification.
Can children with STAR deficiency grow up and have an active life?
With consistent treatment, emergency planning, and follow-up, children with STAR deficiency can grow, learn, and participate in typical childhood activities. Care continues through puberty and adulthood, with specialists monitoring health and discussing fertility and family-planning options when appropriate.

Get notified when new evidence is published on Congenital lipoid adrenal hyperplasia due to STAR deficency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    The Steroidogenic Acute Regulatory (STAR) Gene Anatomy, Expression, and Roles.

    Lim JH, Cheon YP

    Development & reproduction 2025; (29(3)):63-80 doi:10.12717/DR.2025.29.3.63.

    PMID: 41103362
  2. 2

    Disorders in the initial steps of steroid hormone synthesis.

    Miller WL

    The Journal of steroid biochemistry and molecular biology 2017; (165(Pt A)):18-37 doi:10.1016/j.jsbmb.2016.03.009.

    PMID: 26960203
  3. 3

    Clinical spectrum of human STAR variants and their genotype-phenotype correlation.

    Altinkilic EM, Augsburger P, Pandey AV, Flück CE

    The Journal of endocrinology 2024; (262(3)).

    PMID: 38913505
  4. 4

    [Clinical and StAR genetic characteristics of 33 children with congenital lipoid adrenal hyperplasia].

    Zheng WQ, Duan Y, Xiao B, et al.

    Zhonghua er ke za zhi = Chinese journal of pediatrics 2022; (60(10)):1066-1071 doi:10.3760/cma.j.cn112140-20220322-00233.

    PMID: 36207855
  5. 5

    Nonclassic congenital lipoid adrenal hyperplasia diagnosed at 17 months in a Korean boy with normal male genitalia: emphasis on pigmentation as a diagnostic clue.

    Bae H, Kim MS, Park H, et al.

    Annals of pediatric endocrinology & metabolism 2020; (25(1)):46-51 doi:10.6065/apem.2020.25.1.46.

    PMID: 32252217
  6. 6

    Adrenal Crisis in an Adult Patient With Lipoid Congenital Adrenal Hyperplasia due to STAR Protein Mutation.

    Zavgorodneva Z, Kaljevic M, Chen K

    AACE endocrinology and diabetes 2026; (13(5)):788-791 doi:10.1016/j.aed.2026.04.016.

    PMID: 42978993
  7. 7

    Two siblings with lipoid congenital adrenal hyperplasia: first reported case in Serbia and literature review.

    Jesic MD, Kovacevic S, Zdravkovic V, et al.

    Frontiers in endocrinology 2026; (17()):1912249 doi:10.3389/fendo.2026.1912249.

    PMID: 42688021
  8. 8

    Longitudinal Assessment of Illnesses, Stress Dosing, and Illness Sequelae in Patients With Congenital Adrenal Hyperplasia.

    El-Maouche D, Hargreaves CJ, Sinaii N, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(6)):2336-2345 doi:10.1210/jc.2018-00208.

    PMID: 29584889
  9. 9

    A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia.

    Fu R, Lu L, Jiang J, et al.

    Medicine 2017; (96(21)):e6994 doi:10.1097/MD.0000000000006994.

    PMID: 28538409
  10. 10

    Clinical Characteristics and Outcomes of Korean Patients with Lipoid Congenital Adrenal Hyperplasia: An Analysis of Data from the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) Cohort Study.

    Lee Y, Kim M, Lee YJ, et al.

    Endocrinology and metabolism (Seoul, Korea) 2026; (41(4)):566-578 doi:10.3803/EnM.2025.2611.

    PMID: 42190700
  11. 11

    Pubertal Development and Pregnancy Outcomes in 46,XX Patients With Nonclassic Lipoid Congenital Adrenal Hyperplasia.

    Hatabu N, Amano N, Mori J, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(5)):1866-1870 doi:10.1210/jc.2018-01752.

    PMID: 30476142
  12. 12

    StAR Protein Deficiency in Clinical Practice: A Case Series From Saudi Arabia.

    Alabduljabbar A, Farooq D, Abid S, et al.

    Case reports in endocrinology 2026; (2026()):8489134 doi:10.1155/crie/8489134.

    PMID: 41502797
  13. 13

    Frequency of stress dosing and adrenal crisis in paediatric and adult patients with congenital adrenal hyperplasia: a prospective study.

    Tschaidse L, Wimmer S, Nowotny HF, et al.

    European journal of endocrinology 2024; (190(4)):275-283 doi:10.1093/ejendo/lvae023.

    PMID: 38584334

This page explains congenital lipoid adrenal hyperplasia and emergency planning for informational purposes only and does not constitute medical advice. Do not change your child’s medicines or emergency doses without guidance from the pediatric endocrinology team; use the individualized plan for urgent symptoms.